SELZENTRY (ViiV Healthcare Company)
Welcome to the PulseAid listing for the SELZENTRY drug offered from ViiV Healthcare Company. This CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ViiV Healthcare Company |
NON-PROPRIETARY NAME: | maraviroc |
SUBSTANCE NAME: | MARAVIROC |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | CCR5 Co-receptor Antagonist [EPC],Chemokine Co-receptor 5 Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-05-16 |
END MARKETING DATE: | 0000-00-00 |
SELZENTRY HUMAN PRESCRIPTION DRUG Details:
Item Description | SELZENTRY from ViiV Healthcare Company |
LABELER NAME: | ViiV Healthcare Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2011-05-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49702-223_af4a9734-c224-4d54-8247-38e621e64ea3 |
PRODUCT NDC: | 49702-223 |
APPLICATION NUMBER: | NDA022128 |
Other MARAVIROC Pharmaceutical Manufacturers / Labelers: